Johan Rojas set to miss the rest of the season after UCL injury, Phillies outfield situation worsens as PED suspension nears end

Johan Rojas is no longer expected to return to the field this season, adding a new, significant obstacle for the Philadelphia Phillies. Reporting indicates the team’s outfielder is nearing the end of an 80-game performance-enhancing drug suspension that started in March, but he will not play again this year after sustaining a UCL tear that requires season-ending recovery.

The two developments, a PED suspension and an elbow injury, combine to erase what would have been a potential late-season lift for a club looking for consistent production from its outfield. Rojas, an outfield piece whose absence removes depth and can change day-to-day lineup construction, now becomes a roster decision that extends beyond the games he might have returned to this spring.

According to the same report, Rojas tested positive for a banned substance, which led to the 80-game ban announced in March. That timeline has been the main framework for speculation about when he could come back. With the UCL tear pushing his return back into the offseason, the suspension becomes less about immediate on-field impact and more about a longer-term talent evaluation question for the Phillies.

The elbow injury also matters because it affects more than just a player’s availability. A torn UCL typically changes throwing mechanics and workload, and for an outfielder it can alter how quickly a hitter is integrated back into game intensity, even if rehabilitation milestones are reached. The Phillies, therefore, are likely to treat Rojas as a player whose reintroduction will not begin during the current playoff-aimed window.

Philadelphia’s situation now turns on how the organization fills the void in the outfield while staying operationally consistent. Outfield roles often influence pitching matchups as well as defensive planning, and any extended absence from a regular or near-regular can force changes to who gets started in left, center, or right on a given day. Even without specific transaction information, the practical effect is clear: Rojas’ season end increases the burden on remaining outfield depth.

For MLB overall, the case is another reminder that disciplinary actions and injuries can intersect in ways that reshape team-building plans. MLB’s suspension framework is intended to address violations of league policy, but injuries are outside that system, and they can determine whether a player’s eventual eligibility translates into meaningful games for his club. In this instance, the on-field timetable has been overtaken by the injury timetable.

What to watch next is whether the Phillies provide additional confirmation around recovery timelines, and how they distribute outfield at-bats and starts in the coming weeks. With Rojas unavailable, the next meaningful indicator of Philadelphia’s direction will be how quickly other players settle into stable roles, especially against quality pitching as the schedule tightens. Meanwhile, the suspension ending “nearing” point remains important for the team’s offseason planning, even if it arrives too late to help this year’s roster.